Valuation: Doxa AB

Market Cap 630M 63.54M 57.01M 52.71M 47.74M 89.18M 6.05B 90.26M 251M 3.17B 238M 233M 10.05B P/E 2024
-0.38x
P/E 2025 -1.69x
Enterprise Value 2.13B 215M 193M 178M 161M 302M 20.46B 305M 849M 10.71B 806M 789M 33.99B EV / Sales 2024
290x
EV / Sales 2025 102x
Free-Float
35.85%
Yield 2024 *
-
Yield 2025 -
1 day+9.84%
1 week+32.41%
Current month+50.47%
1 month+43.07%
3 months+33.89%
6 months+11.11%
Current year+9.09%
1 week 0.36
Extreme 0.3605
0.48
1 month 0.28
Extreme 0.285
0.48
Current year 0.28
Extreme 0.285
0.48
1 year 0.28
Extreme 0.285
0.55
3 years 0.28
Extreme 0.285
3.82
5 years 0.28
Extreme 0.285
16
10 years 0.28
Extreme 0.285
18.4
Manager TitleAgeSince
Chief Executive Officer 52 10/10/2024
Director of Finance/CFO - 28/04/2026
Director TitleAgeSince
Chairman 66 01/01/2024
Director/Board Member 62 29/04/2025
Director/Board Member 63 29/04/2025
Date Insider Type Main position Quantity % Market Cap. Importance
14/7/26 Buy 100,000 0.0078%
22/5/26 Buy

Chief Executive Officer

863,508 0.0672%
21/5/26 Buy

Chief Executive Officer

2,636,492 0.2051%
Change 5-day change 1-year change 3-year change Capi.($)
+9.84%+32.41%-11.11%-84.00% 57.74M
+0.33%+15.31%+125.23%+1,058.65% 69.72B
-0.46%+0.94%+12.72%+32.84% 39.78B
-1.85%-0.48%+9.86%+94.19% 28.81B
-1.62%+1.27%-4.58%+43.97% 26.9B
-0.54%-3.23%+0.55%-2.81% 26.87B
-0.35%0.00%-20.28%+81.65% 27.72B
0.00%+9.86%+19.25%+223.98% 20.19B
-0.22%+2.40%+20.04%+17.50% 20.62B
-2.17%-0.68%-6.51%+71.64% 19.11B
Average +0.30%+3.16%+14.52%+153.76% 27.98B
Weighted average by Cap. -0.58%+1.51%+34.06%+312.58%

Financials

2024 2025
Net sales 15.5M 1.56M 1.4M 1.3M 1.17M 2.19M 149M 2.22M 6.17M 77.89M 5.86M 5.74M 247M 20.3M 2.05M 1.84M 1.7M 1.54M 2.87M 195M 2.91M 8.09M 102M 7.68M 7.52M 324M
Net income -1.72B -174M -156M -144M -131M -244M -16.55B -247M -686M -8.66B -652M -638M -27.49B -335M -33.82M -30.34M -28.05M -25.41M -47.46M -3.22B -48.04M -134M -1.69B -127M -124M -5.35B
Net Debt 3.56B 359M 322M 298M 270M 504M 34.22B 510M 1.42B 17.91B 1.35B 1.32B 56.85B 1.5B 151M 136M 126M 114M 212M 14.41B 215M 598M 7.54B 568M 556M 23.94B
Projected Income Statement - Annual - Doxa AB
Logo Doxa AB
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Employees
26
Date Price Change Volume
29/10/26 SEK 0.4800 +9.84% 2,010,758
27/10/26 SEK 0.4370 -0.57% 322,840
26/10/26 SEK 0.4395 +9.87% 2,154,583
23/10/26 SEK 0.4000 -1.36% 1,431,612
22/10/26 SEK 0.4055 +11.86% 3,161,468
  1. Stock Market
  2. Stocks
  3. DOXA Stock